These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21935385)

  • 1. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
    Bassetti M; Taramasso L; Nicco E; Molinari MP; Mussap M; Viscoli C
    PLoS One; 2011; 6(9):e24198. PubMed ID: 21935385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
    Sellami A; Sellami H; Néji S; Makni F; Abbes S; Cheikhrouhou F; Chelly H; Bouaziz M; Hammami B; Ben Jemaa M; Khaled S; Ayadi A
    Mycopathologia; 2011 Jun; 171(6):417-22. PubMed ID: 21170738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM; Elizondo M; Ayala J
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
    Ko KS; Lee JY; Song JH; Peck KR
    J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
    Pfaller MA; Moet GJ; Messer SA; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):561-6. PubMed ID: 21115790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.
    Bassetti M; Merelli M; Righi E; Diaz-Martin A; Rosello EM; Luzzati R; Parra A; Trecarichi EM; Sanguinetti M; Posteraro B; Garnacho-Montero J; Sartor A; Rello J; Tumbarello M
    J Clin Microbiol; 2013 Dec; 51(12):4167-72. PubMed ID: 24108614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Grandesso S; Sapino B; Mazzuccato S; Solinas M; Bedin M; D'Angelo M; Gion M
    Infez Med; 2012 Mar; 20(1):25-30. PubMed ID: 22475657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Iatta R; Caggiano G; Cuna T; Montagna MT
    J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
    Oberoi JK; Wattal C; Goel N; Raveendran R; Datta S; Prasad K
    Indian J Med Res; 2012 Dec; 136(6):997-1003. PubMed ID: 23391796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.
    Ma CF; Li FQ; Shi LN; Hu YA; Wang Y; Huang M; Kong QQ
    BMC Infect Dis; 2013 Jul; 13():337. PubMed ID: 23875950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility of Candida isolates at one institution.
    Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J
    Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
    Seneviratne CJ; Wong SS; Yuen KY; Meurman JH; Pärnänen P; Vaara M; Samaranayake LP
    Mycopathologia; 2011 Nov; 172(5):389-95. PubMed ID: 21744043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.